PRESS RELEASE - FOR IMMEDIATE RELEASE

New York, NY – September 12, 2025 – Vibes AI, the pioneering neurotechnology company addressing the Triple Brain Epidemic of neurodegeneration, mental health, and digital overload, today announced that Steve Ardire has joined as a Strategic Advisor.  Known as a full spectrum  “Force Multiplier” for AI early-stage startups, Ardire brings decades of experience advising more than 100  early stage startups helping founders align innovation with real-world market needs, refine product-market fit, compelling narrative and pitch to close funding, and GTM strategies bus dev, marketing, partnerships, sales with smart tactical execution.

“I’m a baby boomer practitioner of Healthspan: The Science of Aging Well so I stay closely attuned to frontier AI startups in human health and cognition. I’m super impressed with Vibes AI vision: voice reveals, sound restores—where everyday wearable devices deliver both early detection of cognitive decline and restorative audio to improve brain health. Vibes AI From Lifespan → Healthspan → JoySpan is creating that future by combining voice biomarkers with sound-based therapeutics to extend JoySpan™— healthy, joyful years of life so excited to help this team bring such a bold vision to fruition and scale,” said Ardire.

“Steve’s reputation for shaping the trajectories of AI startups is special,” said Joanna Peña-Bickley, Founder and CEO of Vibes AI. “His ability to see around corners and translate deep technologies into compelling, investable opportunities is exactly what we need as we scale Vibes AI into a platform that transforms cognitive health for millions.”

About Vibes AI

Vibes AI is a neurotechnology company on a mission to accelerate the world's access to cognitive health & wellness. Founded in 2024, the company uses AI, neuroscience, and ancestral intelligence to create innovative solutions that make cognitive health and enhancement accessible to all. MANTRA, one of the company's flagship products, uses voice biomarker technology to detect early signs of cognitive decline and provide personalized interventions.